Establishing secure connection…Loading editor…Preparing document…

Research Chocolate Study

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH CHOCOLATE STUDY AGREEMENT

Agreement Date:

Parties

Recitals

WHEREAS, Sponsor desires to engage Researcher to conduct the Research Chocolate Study described in this Agreement (the Study) to evaluate sensory attributes, formulation impacts, and consumer preferences for specified chocolate formulations; and

WHEREAS, Researcher has expertise in sensory testing, data collection, and analysis and agrees to perform the Study under the terms and conditions set forth below; and

WHEREAS, Sponsor and Researcher wish to set forth their respective rights and obligations with respect to the Study, ownership of data, confidentiality, compensation and the delivery of results.

Study Identification

Effective Date of Work Commencement:

Scope of Work

Researcher shall perform the tasks and produce the deliverables described below. Researcher shall conduct the Study in a professional manner consistent with industry standards for sensory research and applicable law.

Payment Terms

Total Study Fee: $

Invoices due within days of receipt. Late fee: on overdue amounts.

Payments shall be made to Researcher in U.S. dollars unless otherwise agreed in writing. Sponsor is responsible for any applicable sales, use, withholding or value-added taxes unless Researcher provides a valid exemption document.

Term and Termination

Term Start Date:     Term End Date:

Either party may terminate this Agreement for convenience upon prior written notice to the other party delivered no fewer than days before the effective termination date. Either party may terminate for material breach if the non-breaching party provides written notice and the breach remains uncured for thirty (30) days following such notice.

Upon termination, Researcher shall deliver any completed deliverables and Sponsor shall pay Researcher for all work performed through the termination date, prorated where appropriate. Each party shall return or destroy Confidential Information of the other in accordance with the Confidentiality section.

Confidentiality

"Confidential Information" means non-public information disclosed by one party (the Disclosing Party) to the other (the Receiving Party) that is marked confidential or that a reasonable person would understand to be confidential. Receiving Party shall (a) use Confidential Information solely to perform its obligations under this Agreement; (b) restrict disclosure to those employees, contractors or agents who have a need to know and are bound by confidentiality obligations no less protective than those herein; and (c) protect Confidential Information with at least the same degree of care it uses to protect its own confidential information, but no less than reasonable care.

Confidentiality obligations shall survive termination of this Agreement for a period of from the date of disclosure, except that trade secrets shall remain protected for as long as they remain trade secrets under applicable law. Confidential Information does not include information that: (i) is or becomes generally available to the public other than by breach of this Agreement; (ii) was rightfully known to the Receiving Party prior to disclosure; or (iii) is required to be disclosed by law, provided that the Receiving Party gives prompt written notice to the Disclosing Party to allow the Disclosing Party to seek protective measures.

Intellectual Property and Data

All raw data, study databases, final reports and analyses prepared by Researcher specifically for Sponsor under this Agreement (collectively, Study Data) shall be the exclusive property of Sponsor upon full payment of fees due. Researcher retains the right to use aggregated, anonymized, non-identifiable data and methodological know-how for internal research and publication provided no Sponsor Confidential Information or identifying study results are disclosed without Sponsor's prior written consent.

Researcher warrants that to the best of its knowledge the Study and deliverables will not infringe the intellectual property rights of third parties. Sponsor shall own all intellectual property rights arising from Sponsor-provided materials and any modifications thereto.

Indemnification and Limitation of Liability

Each party shall indemnify, defend and hold harmless the other party and its affiliates from and against third-party claims arising from the indemnifying party's gross negligence, willful misconduct, or material breach of this Agreement. EXCEPT FOR LIABILITY ARISING FROM WILLFUL MISCONDUCT OR GROSS NEGLIGENCE, NEITHER PARTY SHALL BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES OR LOST PROFITS.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict of law principles. The parties submit to the exclusive jurisdiction of the state and federal courts located in that State for disputes arising under this Agreement.

Entire Agreement; Amendment

This Agreement constitutes the entire agreement between the parties with respect to the Study and supersedes all prior and contemporaneous agreements, proposals and communications, whether written or oral. No amendment or modification of this Agreement shall be effective unless in writing and signed by authorized representatives of both parties.

Miscellaneous Provisions

Assignment: Neither party may assign this Agreement without the prior written consent of the other, except to a successor by merger or sale of substantially all assets. Independent Contractor: Researcher is an independent contractor and not an employee, partner or agent of Sponsor. Notices: All notices shall be in writing and delivered to the contact information provided above.

Sponsor Name:

By:

Date:

Researcher Name:

By:

Date:

Enter text✕

What the Research Chocolate Study document is

The Research Chocolate Study is a participant-facing consent and data-collection document used to record informed consent, baseline information, dietary restrictions, and post‑taste feedback for a controlled nutrition or sensory trial focused on chocolate. It defines the study purpose, procedures, expected duration, risks and benefits, data use and retention, and contact details for the principal investigator and study sponsor. When participants sign, the form documents their voluntary agreement to participate. The form can be used as paper consent or as an electronic consent record when executed consistent with ESIGN and applicable state law.

Why a proper Research Chocolate Study form matters

A complete, accurate consent form documents participant authorization, clarifies data handling, supports IRB oversight, and reduces legal and regulatory risk while preserving research integrity and participant safety.

Why a proper Research Chocolate Study form matters

Who typically prepares and completes this study form

Proper use ensures documented consent, regulatory compliance, and defensible study records for audits or publication.

  • Principal investigators and study coordinators who manage recruitment and regulatory submissions.
  • Institutional Review Boards and compliance officers reviewing consent language and data protections.
  • Participants or guardians providing informed consent and required baseline data before participation.

Primary roles that interact with the form

Principal Investigator

Leads study design, approves consent content, and ensures data handling meets regulatory and sponsor obligations; responsible for IRB submissions and for maintaining signed consent records for audits.

Participant / Guardian

Reads study details, confirms understanding, provides required personal data and health disclosures, and signs the form to indicate voluntary consent prior to any study procedures.

Stepwise process to complete the Research Chocolate Study form

Follow these four steps to capture valid consent and participant data before any study activity.

  • 01
    Review Study Info: Read purpose, risks, benefits, and procedures.
  • 02
    Provide Details: Enter personal, health, and contact information.
  • 03
    Acknowledge Consent: Check required consent statements.
  • 04
    Sign and Date: Sign using an accepted electronic or handwritten method.

How electronic completion and submission typically operate

This sequence describes a typical eConsent flow from sending the form to storing the signed record.

  • Upload: Study team uploads consent PDF or DOCX.
  • Place Fields: Add name, date, checkbox, and signature fields.
  • Send to Participant: Deliver via secure email or signing link.
  • Capture Audit Trail: System records timestamp, IP, and signing events.

Typical eConsent workflow settings to configure

Configure these settings before sending to ensure authentication, retention, and accessibility requirements are met.

Field Configuration
Signer Authentication Email + SMS code or ID verification
Document Retention Secure storage with audit trail
Consent Disclosure Include ESIGN consumer disclosure when required
Language Accessibility Provide translated versions where needed

Platform and file requirements for electronic completion

Confirm chosen vendor supports the integrations and compliance frameworks your institution requires before live use.

  • Formats: PDF, DOCX, HTML, Excel
  • Integrations: Salesforce, NetSuite, Google Workspace
  • Security: TLS in transit; AES-256 at rest

Essential sections to include in a professional study consent

A concise consent form should include the items below to meet IRB expectations and participant needs.

Study Identifier

Project title, protocol number, and sponsor details so records and correspondence are unambiguous and audit-ready.

Purpose and Procedures

Plain-language explanation of why the chocolate study is conducted, step-by-step procedures, number of sessions, and estimated time commitment.

Risks and Discomforts

Clear description of foreseeable risks such as allergic reactions, taste aversion, or dietary interactions and mitigation measures.

Potential Benefits

Any expected benefits to participants or society, or statement that participants may not receive direct benefit.

Data Use and Privacy

How data will be stored, who will access it, de-identification steps, and conditions for sharing or publication.

Contacts and Rights

Investigator contact for questions, IRB contact for rights concerns, withdrawal procedures, and how to obtain copies of signed forms.

Security and compliance features for electronic consent

Encryption: AES-256 at rest
In-transit: TLS 1.2/1.3
Audit Trail: Timestamp and IP log
HIPAA: BAA required
ESIGN/UETA: Legal validity
Accessibility: WCAG 2.0 AA support

Consequences of incorrect or missing consent

Invalid Consent: May invalidate collected data
IRB Action: Study suspension or remediation
HIPAA Breach: Regulatory investigation risk
Participant Harm: Increased liability exposure
Publication Risk: Journals may reject data
Civil Claims: Potential litigation exposure

Common mistakes when preparing the Research Chocolate Study form

  • Omitting explicit consent statements for audio or video recording can lead to unusable media and IRB noncompliance.
  • Using ambiguous language about data sharing or publication may prevent participant understanding and impede future data use.
  • Failing to record accurate allergy or medical disclosures increases participant safety risk and can require protocol pauses.
  • Incorrect or missing signature dates create audit findings and may invalidate enrollment dates or safety monitoring timelines.

Timing and critical deadlines to track

Track these time-critical items to remain compliant with IRB and institutional requirements during the lifecycle of the study.

IRB Approval Required:

Obtain approval before any recruitment or data collection.

Consent Before Procedures:

Consent must be executed prior to any study activity.

Data Retention Start:

Retention period begins on consent date or data creation.

Adverse Event Reporting:

Follow IRB/sponsor timelines for reporting safety events.

Final Study Closeout:

Complete data archiving and sign-off per sponsor timeline.

Key milestones from setup to closeout

A sequential view of major administrative and operational milestones for the Research Chocolate Study.

01

Protocol Development

Finalize objectives, methods, and inclusion criteria.

02

IRB Submission

Submit consent and materials for ethics review.

03

Participant Enrollment

Screen and consent eligible participants.

04

Study Closeout

Archive records and report findings.

Representative eSignature vendor pricing and capability snapshot

Basic pricing and feature presence for common eSignature vendors. Place signNow first per comparison guidelines; confirm plan details with each vendor before purchasing.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Real-world examples of eConsent in related contexts

These brief cases show how research or clinical organizations used electronic forms to manage consent and signatures.

Fertility Center Example

A medical center moved patient intake and consent online to reduce in-person paperwork.

  • The approach preserved compliance with privacy rules.
  • The organization reported improved turnaround and consistent document retention that supported audits and patient follow-up.

Research Lab Example

A small research lab used electronic consent to enroll participants across multiple sites.

  • Remote signing enabled faster recruitment.
  • Centralized storage and audit trails simplified IRB reporting and maintained data integrity for publication.

Frequently asked questions about the Research Chocolate Study form

Answers to common practical and legal questions about executing, storing, and validating the study consent form.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users